Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2011

Vestura(Ethinyl Estradiol/Drospirenone)Teva Pharmaceutical Industries Limited logoTEVA

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Teva Pharmaceutical Industries Limited

$51K

Medicare cost, 2024

Medicare drug plans spent $50,811 on Vestura (ethinyl estradiol/drospirenone) in 2024, for 1,256 prescriptions and refills filled by 441 patients. Spending fell 28% from 2023 to 2024. New York accounts for the most spending ($8,680, 17% of the total). It is made by Teva Pharmaceutical Industries Limited (TEVA).

Medicare cost, 2024

$51K

-27.9% from 2023

Prescriptions

1,256

$40.45 per claim

Patients

441

511 prescribers

Total spending, 2024

$51K

$115.22 per patient

Questions and answers

How much does Medicare spend on Vestura?

Medicare prescription drug plans paid $51K for Vestura in 2024, for 1,256 prescriptions and refills to 441 patients (down 27.9% from 2023). The average cost per claim was $40.45.

Which state spends the most on Vestura?

New York had the highest Medicare cost for Vestura in 2024: $8,680 for 217 claims, followed by Ohio ($7,230).

Who prescribes Vestura the most?

Ted G Coy, internal medicine in Southfield, MI, had the highest Medicare cost for Vestura in 2024: 11 claims costing $404.

Who makes Vestura?

Vestura is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva USA, Teva Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Vestura was $51K in 2024, after a high of $72K in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Vestura, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Ted G Coy Southfield, MIInternal Medicine11Under 11$404

Prescriber data by year

YearPrescribersClaimsPatientsCost
20224291,123377$72K
20234461,160406$70K
20245111,256441$51K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Teva USATEVA logoTEVA1,192$48K
Teva PharmTEVA logoTEVA64$2,832

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
1
RxNorm concept IDs
1233850, 630734, 748797, 748798
Application numbers
ANDA078833

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube